We provide the resources and capital healthcare companies need to succeed.
About Three Arch Partners
Three Arch Partners was formed in 1993 to provide young companies with access to relevant clinical and business resources, as well as capital. Three Arch has helped create, build and fund more than 100 important new healthcare companies. These companies have often become the clinical and market leaders in their respective fields, and have generated strong returns. The fund focuses on opportunities in medical devices and healthcare services, and less frequently in biotechnology.
Since inception, Three Arch Partners has focused on identifying and creating new healthcare companies in markets with significant unmet clinical or infrastructure needs. The general partners do not wait for ideas to come to them, but actively create and source technology and management. As often, the fund assists physicians and inventors in establishing companies. Our involvement may include securing capital, assembling management, technical, and regulatory teams, and providing interim operational support.
Venture capital investors do not make companies successful. Our responsibility is to back the right men and women. We provide help when requested or required. Our experience in investing and in entrepreneurship, and our network of academic and industry contacts, help ensure young companies access to key resources. We do not know all of the answers. But we can help understand the problems, and often know someone that can provide specific help. With young companies, the focus is always on reducing the time, risk, and capital requirements from discovery, through product development, to commercialization.
The partnership manages over $1 billion in capital. Three Arch Partners III, a $200 million fund raised in late 1999, is focused on seed and early stage opportunities. Three Arch Capital, a $300 million fund raised in 2000, is focused on development stage companies. Three Arch Partners IV, a $450 million fund, was raised in 2004, invests in seed, early, and development stage companies. Prior funds of $30 million and $80 million were raised in 1994 and 1997.